RecruitingNCT06792188

Smartwatch-Based AI Model for OSA Prediction (SWOSA)

Smartwatch-Based Artificial Intelligence Model for Obstructive Sleep Apnea Prediction


Sponsor

Seoul National University Hospital

Enrollment

147 participants

Start Date

Feb 3, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to develop an artificial intelligence (AI) model for more accurately diagnosing obstructive sleep apnea (OSA) by collecting blood oxygen saturation and other health information during sleep using a smartwatch. OSA is common but often underdiagnosed, and the gold-standard diagnostic test, polysomnography, is costly and time-consuming. Smartwatches can provide a variety of health data, such as sleep patterns, blood oxygen saturation, and heart rate, which can help detect key symptoms and signs of OSA. By developing an AI model that uses smartwatch data to screen for OSA, this study seeks to offer a cost-effective and accessible diagnostic method, ultimately contributing to the early detection and improved treatment rates of OSA.


Eligibility

Min Age: 22 YearsMax Age: 85 Years

Inclusion Criteria1

  • Men and women aged 22 to 85 years who visited Seoul National University Hospital with suspected sleep apnea due to symptoms such as snoring, apnea, or excessive daytime sleepiness.

Exclusion Criteria8

  • Patients previously diagnosed with sleep apnea who are currently undergoing treatment (e.g., positive airway pressure \[PAP\] therapy, mechanical ventilation, oral appliances, or surgery).
  • Patients with neuromuscular diseases or a history of chronic opioid medication use.
  • Patients with severe insomnia that is not controlled by medication.
  • Patients receiving supplemental oxygen therapy due to underlying conditions such as heart failure, chronic obstructive pulmonary disease, interstitial lung disease, hypoventilation syndrome, or stroke, or whose baseline oxygen saturation is less than 90%.
  • Patients with implanted cardiac pacemakers, defibrillators, or other electronic devices.
  • Patients inexperienced in using smartphones, apps, or smartwatches.
  • Pregnant women.
  • Patients unable or unwilling to provide written informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEGalaxy Watch 4, Samsung Electronics Co., Ltd., South Korea

Use of the Galaxy Watch 4 during sleep for approximately two weeks prior to the polysomnography test, including the night of the test.


Locations(1)

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06792188


Related Trials